
Biocon Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon